Clinical Research Group of St. Petersburg

St. Petersburg, Florida 33707

0 studies enrolling now · 14 studies all time

What they study most

Dysthymic Disorder, Excessive Daytime Sleepiness, Excessive Sleepiness, Idiopathic Hypersomnia, Major Depressive Disorder, Narcolepsy, Narcolepsy Without Cataplexy, Obstructive Sleep Apnea, Obstructive Sleep Apnea Syndrome, Obstructive Sleep Apnea/Hypopnea Syndrome (OSAHS), Restless Legs Syndrome, Shift-Work Sleep Disorder

Studies at this site

• This is a Study to Determine the Effect of Multiple Doses of an Investigational Drug, Taken by Mouth, in People With Narcolepsy-cataplexy. Accepting Both Males and Females Ages of 18 Years to 55 Years. This Study Will be Conducted in the US and Will Require Approximately 13 Weeks Participation. — Completed
• A Study of the Safety and Effectiveness of ADX-N05 in the Treatment of Excessive Daytime Sleepiness — Completed
• Non-Inferiority Study of the FRESCA Airbox Positive Airway Pressure System — Completed
• A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy — Completed
• "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA" — Completed
• "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy" — Completed
• "A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA" — Completed
• A Study of Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2 — Completed
• Efficacy and Safety of Pramipexole Compared to Placebo in the Treatment of Restless Legs Syndrome (RLS) — Completed
• Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and Depression — Completed
• Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome — Completed
• Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder — Completed
• Efficacy and Tolerability of Armodafinil in Adults With Excessive Sleepiness Associated With Shift Work Disorder — Completed
• Trial of Effects of Oral Xyrem and Zolpidem on Sleep-Disordered Breathing in Obstructive Sleep Apnea Patients — Completed